News

Termination of the agreement will be effective 90 days from August 22, 2007. As a result, MethylGene will regain exclusive rights to its beta-lactamase inhibitor program to overcome

The studies of PEG-SN38, Enzon’s pegylated form of SN38, the active metabolite of the cancer drug Camptosar, are designed to evaluate the safety, tolerability, and pharmacokinetics of the

In the studies, 30% of StatC-treated lung samples had H5N1 virus detected in comparison to 50% of Tamiflu treated samples, according to the company. Histopathology which measures lung

The placebo-controlled, dose-escalation study is designed to evaluate the safety and tolerability of multiple doses of the antibody. This trial is the second phase IIa study currently underway

Orphan drug status is granted to drug candidates that are developed for severe, disabling diseases for which there are currently no satisfactory products on the market. Moreover, a

The recent approval in South Korea includes both complicated skin and skin structure infections (cSSSI) and right-sided infective endocarditis (SAB/RIE). Cubicin was previously approved in Taiwan (in November

The new entity will have Nordic sales rights for both Orexo’s and ProStrakan’s portfolio including Tostrex, Rectogesic and Droperidol, followed by Rapinyl, Orexo’s patented product for the treatment

Vaccinated travelers were 75% less likely to suffer moderate or severe diarrhea from any cause and 84% less likely to be afflicted by severe diarrhea, according to the

This facility, which has the ability to manufacture lyophilized powders, suspension products, and aqueous and oil solutions, currently manufactures products for both Watson and other third parties, according